日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial

建立多变量模型预测意义未明的单克隆丙种球蛋白病患者骨髓取样需求:一项嵌套于临床试验中的队列研究

Eythorsson, Elias; Rognvaldsson, Saemundur; Thorsteinsdottir, Sigrun; Einarsson Long, Thorir; Reed, Elin Ruth; Sigurdardottir, Gudrun Asta; Vidarsson, Brynjar; Onundarson, Pall Torfi; Agnarsson, Bjarni A; Sigurdardottir, Margret; Olafsson, Isleifur; Thorsteinsdottir, Ingunn; Sveinsdottir, Signy Vala; Sigurdsson, Fridbjorn; Thordardottir, Asdis Rosa; Palsson, Runolfur; Indridason, Olafur Skuli; Jonsson, Asbjorn; Gislason, Gauti Kjartan; Olafsson, Andri; Sigurdsson, Jon; Steingrimsdottir, Hlif; Hultcrantz, Malin; Durie, Brian G M; Harding, Stephen; Landgren, Ola; Aspelund, Thor; Love, Thorvardur Jon; Kristinsson, Sigurdur Yngvi

Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases: Findings From the NRG-BR001 Phase 1 Trial

立体定向放射治疗治疗多发性转移瘤患者的安全性评价:NRG-BR001 1期试验结果

Chmura, Steve; Winter, Kathryn A; Robinson, Clifford; Pisansky, Thomas M; Borges, Virginia; Al-Hallaq, Hania; Matuszak, Martha; Park, Sean S; Yi, Sun; Hasan, Yasmin; Bazan, Jose; Wong, Philip; Yoon, Harold A; Horton, Janet; Gan, Gregory; Milano, Michael T; Sigurdson, Elin Ruth; Moughan, Jennifer; Salama, Joseph K; White, Julia

Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204

局部晚期直肠癌患者术前放疗联合卡培他滨、奥沙利铂和贝伐单抗化疗,随后行手术,术后行5-氟尿嘧啶、亚叶酸钙、奥沙利铂(FOLFOX)和贝伐单抗化疗的II期临床试验:5年临床结果 ECOG-ACRIN癌症研究组 E3204

Landry, Jerome C; Feng, Yang; Prabhu, Roshan S; Cohen, Steven J; Staley, Charles A; Whittington, Richard; Sigurdson, Elin Ruth; Nimeiri, Halla; Verma, Udit; Benson, Al Bowen

Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204

一项针对局部晚期直肠癌患者的II期研究,评估术前放疗联合卡培他滨、奥沙利铂和贝伐单抗治疗,随后进行手术,术后给予5-氟尿嘧啶、亚叶酸钙、奥沙利铂(FOLFOX)和贝伐单抗治疗的疗效:ECOG 3204

Landry, Jerome C; Feng, Yang; Cohen, Steven J; Staley, Charles A 3rd; Whittington, Richard; Sigurdson, Elin Ruth; Nimeiri, Halla; Verma, Udit; Prabhu, Roshan S; Benson, Al Bowen